The Journal of Spinal Cord Medicine, 2020 · DOI: 10.1080/10790268.2019.1575533 · Published: January 1, 2020
This review focuses on spasticity in individuals with spinal cord damage (SCD) and aims to provide guidance on measuring health-related quality of life (HRQoL) in this population. The use of patient-reported outcome measures (PROMs) is important to fully understand the impact of spasticity on an individual's daily life and well-being, as there can be discrepancies between a patient's perception of spasticity and a clinician's findings. HRQoL measures and caregiver burden assessments are valuable for evaluating treatment effectiveness and are increasingly important to healthcare payers in determining the merits of new and existing treatments.
Clinicians should consider using PROMs, especially condition-specific ones like PRISM or SCI-SET, alongside generic measures like SF-36, to get a comprehensive view of spasticity's impact on patients with SCD.
Researchers should utilize a combination of condition-specific and generic HRQoL measures, considering preference-based measures if economic evaluation is needed. Further research is needed to validate adapted versions of SF-36 and caregiver burden measures specific to SCD.
Healthcare payers should consider HRQoL data from PROMs when evaluating new and existing spasticity treatments to ensure funding for interventions that demonstrate clear patient benefit.